Key programs include avexitide for post-bariatric hypoglycemia, AMX0035 for Wolfram syndrome, AMX0114 for amyotrophic lateral sclerosis, and AMX0318, a novel long-acting GLP1 receptor antagonist being advanced through INDenabling preclinical studies
Prescription products require a consultation with a healthcare provider who will determine if a prescription is appropriate for you
The real success is being able to treat obesity, and thats what we should stick to
Lower concentrations produce slower or less noticeable results
However, some possible side effects of this peptide combination that may occur in some individuals include: Water retention Mild headaches Injection site irritation In rare cases, slight dizziness and temporary flushing may be seen
Suitable alternatives include